Company Profile
AKESO
Description
Akeso, Inc., a biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer (GC), gastroesophageal junction (GEJ) cancer, ESCC, hepatocellular carcinoma (HCC), small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), pancreatic cancer, and solid tumors; and AK112, a PD-1/VEGF bi-specific antibody to treat NSCLC, triple-negative breast cancer (TNBC), head and neck cancer, HCC, colorectal and ovarian cancer, and solid tumors. It is also developing AK117, a CD47 monoclonal antibody to treat myelodysplastic syndrome, acute myeloid leukemia, GC, GEJ, ESCC, HNSCC, CRC, TNBC, and solid tumors/lymphoma; AK105, a PD-1 monoclonal antibody to treat classic Hodgkin's lymphoma (R/R cHL), NSCLC, NPC, HCC, SCLC, thyroid cancer, mesothelioma and thymic cancer, ESCC, UC, GC, GEJ, cholangiocarcinoma, neuroendocrine tumor, and mismatch repair deficient solid tumor; AK119, a CD73 monoclonal antibody for treating solid tumors and NSCLC; and AK109, a VEGFR-2 monoclonal antibody to treat GC, GEJ, NSCLC, HCC, and solid tumors. In addition, the company develops AK102, a PCSK9 monoclonal antibody to treat hypercholesterolemia and mixed hyperlipidemia; AK101, an IL-12/IL-23 monoclonal antibody to treat moderate-to-severe psoriasis and ulcerative colitis; AK111, an IL-17 monoclonal antibody to treat moderate-to-severe psoriasis and ankylosing spondylitis; and AK120, an IL-4R monoclonal antibody to treat moderate-to-severe atopic dermatitis. Further, its preclinical product includes AK127, a TIGIT monoclonal antibody to treat solid tumors; and AK115, a NGF monoclonal antibody. The company has collaboration agreements with Pfizer Pharmaceuticals; AstraZeneca Pharmaceuticals; Summit Therapeutics Inc.; and Shenzhen Chipscreen Biosciences Co., Ltd. Akeso, Inc. was founded in 2012 and is headquartered in Zhongshan, the People's Republic of China.
Reports
This company has 3 ESG reports available.
ESG Performance Overview
Select a KPI indicator to view performance trend
KPI Indicators
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
12 Data PointsIndicator | Data Points | Actions |
---|---|---|
Total GHG Emissions Intensity (By Employee) | 3 | |
Total GHG Emissions | 3 | |
Direct GHG Emissions (Scope 1) | 3 | |
Indirect Energy Emissions (Scope 2) | 3 |
A1.3 Hazardous Waste
4 Data PointsIndicator | Data Points | Actions |
---|---|---|
Total Hazardous Waste Intensity (By Employee) | 2 | |
Total Hazardous Waste | 2 |
A1.4 Non-Hazardous Waste
4 Data PointsIndicator | Data Points | Actions |
---|---|---|
Non-Hazardous Waste Disposed | 2 | |
Total Non-Hazardous Waste Intensity (By Employee) | 2 |
A2.1 Energy Consumption
22 Data PointsIndicator | Data Points | Actions |
---|---|---|
Purchased Electricity Intensity (By Employee) | 1 | |
Energy Consumption Intensity (By Employee) | 1 | |
Total Energy Consumption | 1 | |
Gasoline Consumption | 4 | |
Diesel Fuel Consumption | 4 | |
Natural Gas Consumption | 4 | |
Purchased Electricity | 3 | |
Purchased Steam | 4 |
A2.2 Water Consumption
2 Data PointsIndicator | Data Points | Actions |
---|---|---|
Discharge of Industrial Wastewater | 1 | |
Municipal Water Consumption | 1 |
A2.5 Total Packaging Material Used
1 Data PointsIndicator | Data Points | Actions |
---|---|---|
Packaging Material Consumption (Paper) | 1 |
B1.1 Amount and Distribution of Workforce
33 Data PointsIndicator | Data Points | Actions |
---|---|---|
Number of Total Employees | 3 | |
Number of Male Employees | 3 | |
Number of Female Employees | 3 | |
Percentage of Male Employees | 3 | |
Percentage of Female Employees | 3 | |
Number of Employees Aged Below 30 | 3 | |
Number of Employees Aged 30-50 | 3 | |
Number of Employees Aged Above 50 | 3 | |
Percentage of Employees Aged Below 30 | 3 | |
Percentage of Employees Aged 30-50 | 3 | |
Percentage of Employees Aged Above 50 | 3 |
B1.2 Employee Turnover Rate
19 Data PointsIndicator | Data Points | Actions |
---|---|---|
Turnover Rate of Female Employees | 3 | |
Turnover Rate of Male Employees | 3 | |
Turnover Rate of Employees Aged Below 30 | 3 | |
Turnover Rate of Employees Aged 30-50 | 3 | |
Turnover Rate of Employees Aged Above 50 | 3 | |
Turnover Rate of Total Employees | 3 | |
Turnover Rate of Employees in Overseas | 1 |
B3.1 The Percentage of Employees Trained
18 Data PointsIndicator | Data Points | Actions |
---|---|---|
Percentage of Employees Trained | 3 | |
Percentage of Trained Male Employees | 3 | |
Percentage of Trained Female Employees | 3 | |
Percentage of Trained Senior Management | 3 | |
Percentage of Trained Middle Management | 3 | |
Percentage of Trained General Employees | 3 |
B3.2 Average Training Hours Completed per Employee
18 Data PointsIndicator | Data Points | Actions |
---|---|---|
Average Training Hours per Employee | 3 | |
Average Training Hours (Male) | 3 | |
Average Training Hours (Female) | 3 | |
Average Training Hours (Senior Management) | 3 | |
Average Training Hours (Middle Management) | 3 | |
Average Training Hours (General Staff) | 3 |
ESG Reports
Year | Report Title | Publication Date | Raw KPIs | Standard KPIs | Processed | Actions |
---|---|---|---|---|---|---|
2024 | 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 2025-04-29 | 51 | 46 | Yes | |
2023 | 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 2024-04-29 | 57 | 44 | Yes | |
2022 | 2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 2023-04-27 | 54 | 43 | Yes |